Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Morphometric Quantification of Steatosis and Fibrosis in Metabolic Liver Disease Associated With Type 2 Diabetes
Clinical Gastroenterology and Hepatology
May 2026
Fourati O.
Double Graph Attention Network for predicting non-alcoholic fatty liver disease in patients with type 2 diabetes
Artificial Intelligence in Medicine
April 2026
Chen T.
A Scoping Review of the Photographic Assessment of Donor Liver Steatosis in Transplantation Using Artificial Intelligence
Clinical Transplantation
February 2026
Kourounis G.
Open Access
Recent Advances in the Application of Machine Learning Models in Metabolic Dysfunction–Associated Steatotic Liver Disease
Diabetes Metabolism Research and Reviews
February 2026
Yang F.
Artificial intelligence in metabolic dysfunction-associated steatotic liver disease: Transforming diagnosis and therapeutic approaches
World Journal of Gastroenterology
14 January 2026
Hernández-Almonacid P.G.
Open Access
CONTEST: A generalization of ONEST to estimate sample size for predictive augmented intelligence method validation studies
Journal of Pathology Informatics
November 2025
Olson B.K.
Open Access
Deep learning for automated boundary detection and segmentation in organ donation photography
Innovative Surgical Sciences
1 September 2025
Kourounis G.
Open Access
Defining an NK Cell–enriched Rejection-like Phenotype in Liver Transplant Biopsies From the INTERLIVER Study
Transplantation
1 August 2025
Madill-Thomsen K.S.
Open Access
Limited use of FIB-4 index in patients under 65 years of age with type 2 diabetes mellitus
Hepatology Research
April 2025
Kim M.
Open Access
Comparison of the diagnostic accuracy of shear wave elastography with transient elastography in adult nonalcoholic fatty liver disease: a systematic review and network meta-analysis of diagnostic test accuracy
Abdominal Radiology
February 2025
Yamaguchi R.
Open Access
Exposure–response modeling of liver fat imaging endpoints in non-alcoholic fatty liver disease populations administered ervogastat alone and co-administered with clesacostat
Cpt Pharmacometrics and Systems Pharmacology
February 2025
Hughes J.H.
Open Access
Deep Parenchymal Steatosis Assessment and Quantification in Histopathology
IEEE Access
2025
Gupta R.
Open Access
Classification of the Stages of Nonalcoholic Steatohepatitis via Federated General Visual Representation Learning
International Journal of Imaging Systems and Technology
July 2024
Nergiz M.
Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis
Hepatology
July 2024
Ratziu V.
Open Access
This Is What Metabolic Dysfunction–Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol
Seminars in Liver Disease
19 June 2024
Fischer A.M.
Open Access
Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction–associated steatohepatitis
Hepatology Communications
10 May 2024
Younossi Z.M.
Open Access
Modernizing metabolic dysfunction-associated steatotic liver disease diagnostics: the progressive shift from liver biopsy to noninvasive techniques
Therapeutic Advances in Gastroenterology
January-December 2024
Hudson D.
Open Access
Precision diagnostics in transplanted organs using microarray-assessed gene expression: concepts and technical methods of the Molecular Microscope® Diagnostic System (MMDx)
Clinical Science
2024
Madill-Thomsen K.S.
Open Access
Head-to-head comparison of magnetic resonance elastography-based liver stiffness, fat fraction, and T1 relaxation time in identifying at-risk NASH
Hepatology
October 2023
Li J.
Open Access
An unsupervised transfer learning model based on convolutional auto encoder for non-alcoholic steatohepatitis activity scoring and fibrosis staging of liver histopathological images
Neural Computing and Applications
May 2023
Karagoz M.A.
State of the art on the pathophysiology, diagnosis and treatment of non-alcoholic steatohepatitis (NASH)
Annales Pharmaceutiques Francaises
March 2023
Grzych G.
Open Access
Artificial intelligence and deep learning: New tools for histopathological diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Computational and Structural Biotechnology Journal
January 2023
Takahashi Y.
Open Access